← Evidence map

ArticleBlood cancer journal2026

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma.

Hamza Hashmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2026

this papercites it

Functionally high-risk disease is associated with poor outcomes after late-line CAR T-cell therapy for multiple myeloma. | OpenQuestion